HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS - ANVISA Registration 80502070015

Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80502070015 and manufactured by MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA. The registration is held by MOBIUS LIFE SCIENCE INDUSTRIA E COMERCIO DE PRODUTOS PARA LABORATORIOS LTDA with validity until Aug 10, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80502070015
Registration Details
ANVISA Registration Number: 80502070015
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

XGEN MASTER CMV - Kit Master para Quantificação de Citomegalovírus (CMV) - XGEN-CMV-MB
Risk Class IV

Registration Details

80502070015

25351664546201484

04645160000149

Dates and Status

Aug 10, 2015

10/08/2035

09/18/2025 19:00:01